Lochner Daniel
CIK 0001791187
Chief Financial Officer
Filings
9
Latest Mar 5, 2026
Issuers covered
2
Showing
9 of 9
Page 1
Track record
1 of 2 open-market trades scored (50% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -50.5% | -50.5% | -50.5% | -50.5% |
| 90 days | 1 | 0% | -59.6% | -59.6% | -59.6% | -59.6% |
| 180 days | 1 | 0% | -54.8% | -54.8% | -54.8% | -54.8% |
| 365 days | 1 | 0% | -51.2% | -51.2% | -51.2% | -51.2% |
Issuers
Companies where Lochner Daniel has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AVRO | Avrobio, Inc. | 7 | Mar 5, 2026 |
| OYST | Oyster Point Pharma, Inc. | 2 | Jan 4, 2023 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|